Logo

Orange Book: Approved Drug Products with Therapeutic Equivalence

Small book cover: Orange Book: Approved Drug Products with Therapeutic Equivalence

Orange Book: Approved Drug Products with Therapeutic Equivalence

Publisher: U.S. Department of Health and Human Services
Number of pages: 1252

Description:
The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).

Home page url

Download or read it online for free here:
Download link
(19MB, PDF)

Similar books

Book cover: Genome-Based Therapeutics: Targeted Drug Discovery and DevelopmentGenome-Based Therapeutics: Targeted Drug Discovery and Development
- National Academies Press
Objectives: to examine the impact of and investment in genetic and genomic technologies and data in drug development; to examine the challenges for incorporating genomic technologies into drug development and to to remedy those challenges.
(9957 views)
Book cover: Pain Relief: From Analgesics to Alternative TherapiesPain Relief: From Analgesics to Alternative Therapies
by - InTech
This book comprises many aspects of pain treatment and the drugs involved in it. From old analgesics for pain alleviation to analgesics potential for diminishing oxidative stress; from pharmacological therapies to electrical ones ...
(7696 views)
Book cover: Drug-Acceptor InteractionsDrug-Acceptor Interactions
by - Co-Action Publishing
This book is a survey of, and evaluates, analytical tools used to determine equilibrium effects of the interactions between ligands and receptive units as obtained from dose-response experimentation and from combinatorial drug therapy.
(10320 views)
Book cover: Improving and Accelerating Therapeutic Development for Nervous System DisordersImproving and Accelerating Therapeutic Development for Nervous System Disorders
- National Academies Press
The aim was to examine opportunities to accelerate drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling faster entry of potential treatments into first-in-human trials.
(8091 views)